[Demonstration of antidepressant activity on a neurophysiologic model].
D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D001535:Benactyzine / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D003891:Desipramine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004316:Doxepin / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007046:Hysteria / Q000188:drug therapy*; D007099:Imipramine / Q000627:therapeutic use*; D011817:Rabbits; D012601:Scopolamine / Q000627:therapeutic use
D004316:Doxepin; D002110:Caffeine; D001535:Benactyzine; D002707:Chlordiazepoxide; D000661:Amphetamine; D012601:Scopolamine; D006220:Haloperidol; D007099:Imipramine; D003891:Desipramine; D002746:Chlorpromazine
Vyiavlenie antidepressivnoĭ aktivnosti na neĭrofiziologicheskiĭ modeli.